Market Tracker

01/17 3:37am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

5.34
Delayed Data
As of Jan 16
 -0.53 / -9.03%
Today’s Change
0.94
Today|||52-Week Range
6.74
+59.88%
Year-to-Date

Today’s Trading

Previous close5.87
Today’s open6.15
Day’s range5.03 - 6.74
Volume3,182,233
Average volume (3 months)673,944
Market cap$209.2M
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+32.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book63.28

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc+0.05+2.50%
TRILTrillium Therapeutic...+0.15+1.89%
VRMLVermillion Inc+0.06+3.64%
IDXGInterpace Diagnostic...-0.05-4.26%
Data as of 4:00pm ET, 01/16/2018

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts